Cargando…

Knockdown of CHCHD2 inhibits migration and angiogenesis of human renal cell carcinoma: A potential molecular marker for treatment of RCC

Coiled-coil-helix-coiled-coil-helix domain-containing protein 2 (CHCHD2), a novel cell migration determinant, is able to co-express with other genes of the oxidative phosphorylation pathway by using a computational expression screening technique. However, little is known about the expression and bio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Qian, Qu, Debao, Lu, Zheng, Zhang, Longzhen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313053/ https://www.ncbi.nlm.nih.gov/pubmed/30655828 http://dx.doi.org/10.3892/ol.2018.9686

Ejemplares similares

Inhibition of angiogenic and non-angiogenic targets by sorafenib in renal cell carcinoma (RCC) in a RCC xenograft model
por: Yuen, J S P, et al.
Publicado: (2011)

CHCHD2 and CHCHD10 regulate mitochondrial dynamics and integrated stress response
por: Ruan, Yu, et al.
Publicado: (2022)

Neurodegeneration-associated mitochondrial proteins, CHCHD2 and CHCHD10–what distinguishes the two?
por: Ikeda, Aya, et al.
Publicado: (2022)

CHCHD2 and CHCHD10: Future therapeutic targets in cognitive disorder and motor neuron disorder
por: Jiang, Tianlin, et al.
Publicado: (2022)

Urine Metabolomics for Renal Cell Carcinoma (RCC) Prediction: Tryptophan Metabolism as an Important Pathway in RCC
por: Liu, Xiaoyan, et al.
Publicado: (2019)

PD-linked CHCHD2 mutations impair CHCHD10 and MICOS complex leading to mitochondria dysfunction
por: Zhou, Wei, et al.
Publicado: (2019)

Knockdown of SETD2 promotes erastin-induced ferroptosis in ccRCC
por: Xue, Wei, et al.
Publicado: (2023)

Risk of infections in renal cell carcinoma (RCC) and non-RCC patients treated with mammalian target of rapamycin inhibitors
por: Kaymakcalan, M D, et al.
Publicado: (2013)

Crossing Paths in Human Renal Cell Carcinoma (hRCC)
por: Gallego, Guadalupe Aparicio, et al.
Publicado: (2012)

PLEKHO1 knockdown inhibits RCC cell viability in vitro and in vivo, potentially by the Hippo and MAPK/JNK pathways
por: Yu, Zi, et al.
Publicado: (2019)

CHCHD2 connects mitochondrial metabolism to apoptosis
por: Liu, Yong, et al.
Publicado: (2015)

CHCHD2 promotes hepatocellular carcinoma and indicates poor prognosis of hepatocellular carcinoma patients
por: Yao, Yang, et al.
Publicado: (2019)

Twin CHCH Proteins, CHCHD2, and CHCHD10: Key Molecules of Parkinson’s Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia
por: Imai, Yuzuru, et al.
Publicado: (2019)

Knockdown of Pyruvate Kinase M2 Inhibits Cell Proliferation, Metabolism, and Migration in Renal Cell Carcinoma
por: Dey, Prasanta, et al.
Publicado: (2019)

Knockdown of Serine–Arginine Protein Kinase 1 Inhibits the Growth and Migration in Renal Cell Carcinoma Cells
por: Han, Xingtao, et al.
Publicado: (2017)

Knockdown of Long Noncoding RNA FTX Inhibits Proliferation, Migration, and Invasion in Renal Cell Carcinoma Cells
por: He, Xiangfei, et al.
Publicado: (2017)

Molecular subtypes and prognosis in RCC
por: Beuselinck, Benoit, et al.
Publicado: (2015)

Systemic therapy in metastatic renal cell carcinoma (mRCC): an evidence-based recommendation of the German interdisciplinary RCC guidelines group
por: Grünwald, V., et al.
Publicado: (2022)

Characteristics of Clear Cell Papillary Renal Cell Carcinoma (ccpRCC)
por: Rysz, Jacek, et al.
Publicado: (2021)

VHL-Mediated Regulation of CHCHD4 and Mitochondrial Function
por: Briston, Thomas, et al.
Publicado: (2018)

Chchd10 is dispensable for myogenesis but critical for adipose browning
por: Xia, Wei, et al.
Publicado: (2022)

The immune‐related biomarker TEK inhibits the development of clear cell renal cell carcinoma (ccRCC) by regulating AKT phosphorylation
por: Chen, Siming, et al.
Publicado: (2021)

FRI118 3D Reconstruction Of Mitochondria From Human Heart Failure Structures Is Associated With Alterations In CHCHD6 And CHCHD3 Expression
por: Gail Marshall, Andrea, et al.
Publicado: (2023)

Knockdown of Lumican Inhibits Proliferation and Migration of Bladder Cancer
por: Mao, Weipu, et al.
Publicado: (2019)

p53 is functionally inhibited in clear cell renal cell carcinoma (ccRCC): a mechanistic and correlative investigation into genetic and molecular characteristics
por: Diesing, Karoline, et al.
Publicado: (2021)

Safety and clinical efficacy of everolimus in the treatment of advanced renal cell carcinoma (RCC)
por: Shahani, Rohan, et al.
Publicado: (2010)

Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours
por: Wah, Tze M, et al.
Publicado: (2014)

OPtimal Treatment by Invoking biologic clusters in renal cell carcinoma (OPTIC RCC)
por: Beckermann, Kathryn, et al.
Publicado: (2023)

Co-Expression of Multiple PAX Genes in Renal Cell Carcinoma (RCC) and Correlation of High PAX Expression with Favorable Clinical Outcome in RCC Patients
por: Li, Lei, et al.
Publicado: (2023)

RUNX3 Suppresses Migration, Invasion and Angiogenesis of Human Renal Cell Carcinoma
por: Chen, Feifei, et al.
Publicado: (2013)

Cyclic adenosine monophosphate response element-binding protein transcriptionally regulates CHCHD2 associated with the molecular pathogenesis of hepatocellular carcinoma
por: SONG, RUI, et al.
Publicado: (2015)

CHCHD4 Regulates Intracellular Oxygenation and Perinuclear Distribution of Mitochondria
por: Thomas, Luke W., et al.
Publicado: (2017)

Neuropathologic description of CHCHD10 mutated amyotrophic lateral sclerosis
por: Keith, Julia L., et al.
Publicado: (2020)

CHCHD4 (MIA40) and the mitochondrial disulfide relay system
por: Al-Habib, Hasan, et al.
Publicado: (2021)

Corrigendum: VHL-Mediated Regulation of CHCHD4 and Mitochondrial Function
por: Briston, Thomas, et al.
Publicado: (2021)

CHCHD2: The Power House's Potential Prognostic Factor for Cancer?
por: Gundamaraju, Rohit, et al.
Publicado: (2021)

Clinical and Pathological Complete Remission in a Patient With Metastatic Renal Cell Carcinoma (mRCC) Treated With Sunitinib: Is mRCC Curable With Targeted Therapy?
por: Shah, Amishi Y., et al.
Publicado: (2015)

Knockdown of SOX18 inhibits the proliferation, migration and invasion of hepatocellular carcinoma cells
por: WANG, GUIMING, et al.
Publicado: (2015)

Knockdown of NDUFC1 inhibits cell proliferation, migration, and invasion of hepatocellular carcinoma
por: Han, Fang, et al.
Publicado: (2022)

Identification of an apoptosis-related prognostic gene signature and molecular subtypes of clear cell renal cell carcinoma (ccRCC)
por: Zhong, Weimin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o3dst9qoanm3th37p049oo3tjl